Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page shows a new revision label: v3.5.4 replaces v3.5.3, representing a minor update to the record. This update appears to be administrative and does not alter study details or outcomes.
    Difference
    0.0%
    Check dated 2026-05-16T00:12:02.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    No additions or deletions were provided in the website_changes data. This indicates that the page content underwent no recorded textual changes based on the supplied input.
    Difference
    0.0%
    Check dated 2026-05-07T22:48:31.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.5.2 to v3.5.3. This is a small version update and does not alter the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-30T17:48:47.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:56:26.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no substantive changes to the study page content.
    Difference
    0.0%
    Check dated 2026-03-18T17:51:02.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:19:28.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.